The acquisition adds a differentiated BTK inhibitor to the pipeline, enabling parallel development in food allergy, CSU, and MS, funded by $200M in new financing. Phase II studies are set to begin in 2026, targeting large unmet needs with a once-daily oral therapy.Based on Processa Pharmaceuticals…
Record H1 net profit and assets, with strong net inflows and double-digit fee growth. Guidance for higher net inflows and stable margins maintained, despite a one-off tax charge and expected cost spike from growth investments.Based on Banca Generali S.p.A. [BGN] Q2 2026 Audio Transcript — Jul. 29 2…
RNS Number : 4272O FIL Limited 29 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DIS…
Five accomplished women to be honored for their outstanding contributions to architecture, sustainability, design leadership, and educationNEW YORK CITY, NY / ACCESS Newswire / July 29, 2026 / Architectural Record announces the recipients of its 2026 Women in Architecture Awards. Now in its 13th ye…
MONTEREY PARK, CA / ACCESS Newswire / July 29, 2026 / Maison Solutions Inc. NASDAQ:MSS ("Maison Solutions" or the "Company"), a specialty grocery retailer offering traditional Asian food and merchandise to U.S. consumers, today issued the following letter to shareholders from John Xu, Chairman, Pre…
Q2 2026 saw 7% organic sales growth and 15% adjusted EPS growth, but full-year guidance was lowered due to declines in WATCHMAN and EP businesses. A restructuring program aims to deliver $500M in savings by 2029, with growth expected to re-accelerate in 2028 as new products and acquisitions come on…
Record Glo Fiber net additions and strong fiber revenue growth drove a 5.5% increase in consolidated revenue and a 12.9% rise in adjusted EBITDA. Fiber now accounts for over half of total revenue, with positive free cash flow expected in 2027 and EBITDA margins targeted to reach 40% in the next few…
Core EPS rose 30% on 16% revenue growth, with all segments delivering strong double-digit gains. Data center and infrastructure services led performance, prompting a raised full-year Core EPS outlook to $7.80-$7.90 and at least 15% growth targeted for 2027.Based on CBRE Group Inc [CBRE] Q2 2026 Aud…
Xcel Energy elected Peter Carter to its Board effective July 29, 2026, and appointed him to the Audit Committee and the Governance, Compensation and Nominating Committee.Original SEC Filing: XCEL ENERGY INC [ XEL ] - 8-K - Jul. 29, 2026This is an AI-powered summary. It may contain inaccuracies. Con…
RNS Number : 4271O FIL Limited 29 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DIS…
Net income rose 47% quarter-on-quarter, with adjusted EBITDA more than doubling year-on-year. Despite the 8% commission cap impacting on-demand EBITDA, both on-demand and fintech segments remained profitable, and full-year group guidance was maintained.Based on PT GoTo Gojek Tokopedia Tbk [GOTO] Q2…
LAGOS, NIGERIA / ACCESS Newswire / July 29, 2026 / Jumia Technologies AG NYSE:JMIA ("Jumia") today announced that it will release results for the second quarter 2026 before the U.S. market opens on Wednesday, August 12, 2026.Management will host a conference call to discuss the quarter's results at…
REYKJAVIK, ICELAND (July 29, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S Food and Drug Administration (FDA) has closed its inspe…
RNS Number : 4269O FIL Limited 29 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DIS…
Q2 results exceeded expectations, driven by VWR's return to organic growth and strong BMP order trends. Guidance for 2026 was raised, with accelerating growth expected in H2 and continued strong free cash flow supporting debt reduction.Based on Avantor, Inc. [AVTR] Q2 2026 Audio Transcript — Jul. 2…
Record Q2 and first half revenues were driven by broad-based business strength, robust M&A activity, and strong client engagement. Investments in talent and technology, along with a healthy backlog, support a positive outlook for the remainder of 2026 and beyond.Based on Evercore Inc. [EVR] Q2 2026…
NATURAL HEALTH TRENDS CORP reported results for the 2026 quarter, with revenue of $7.6M, a net loss of ($451K) and diluted EPS of ($0.05), versus revenue of $9.81M, net income of $15K and EPS of $0 in the prior-year quarter.Financial Highlights¹ Reported as “Net sales”. ² Reported as “Net income (l…
Processa acquires Vidya in a stock-for-stock deal, adding a differentiated BTK inhibitor and securing $200M in financing to fund parallel phase II studies in food allergy, CSU, and MS, with data expected in 2027–2028. The deal targets large unmet needs and multi-billion dollar markets.Based on Proc…
Record H1 2026 net profit of EUR 617 million and 16% return on tangible book value, with upgraded guidance for NII, service revenues, and CET1 ratio. Asset quality and efficiency remain strong, while capital distribution and digital initiatives advance.Based on Piraeus Bank S.A. [TPEIR] Q2 2026 Aud…
Passenger traffic and revenue grew strongly in H1 2026, with net profit exceeding €1 billion for the first time. Commercial and international segments outperformed, while CapEx and dividend payments increased leverage. Outlook remains cautious due to regulatory and macro uncertainties.Based on Aena…
